How long do you simmer a stew before the ingredients stop tasting like strangers and start acting like a recipe? That is basically the problem in brain biology. You can grind tissue into molecular soup and learn a lot, but then you lose who was standing next to whom in the pan. The review by Wang and Dwivedi looks at the tools trying to fix that: single-cell transcriptomics, which reads gene activity one cell at a time, and spatial transcriptomics, which keeps those cells in place so timing and location do not vanish like steam off a saucepan (Wang and Dwivedi, 2026).

The Brain Is Not a Smoothie

For years, brain molecular biology often worked like this: take a chunk of tissue, blend it, measure the genes, and hope the average tells the truth. Sometimes it does. Sometimes it lies to your face with statistical confidence.

Single-cell RNA sequencing changed the game by letting researchers ask what each cell is doing instead of what the neighborhood average claims everybody is doing. Recent reviews show how useful that has been for spotting vulnerable cell types and inflammatory states in brain disease (Piwecka et al., 2023) (Bonev et al., 2024).

But there is a catch. To do classic single-cell work, you usually dissociate the tissue. Useful, yes. Elegant, not exactly. It is like disassembling a clock to understand time, then realizing you no longer know which gear touched which spring.

Spatial Transcriptomics Is the Seating Chart

Spatial transcriptomics adds the missing coordinate system. Instead of only asking which genes are active, it asks where that activity sits in intact tissue. That matters in neuroscience because location is not decorative. A neuron in the wrong layer or a glial cell clustering around a plaque can mean very different things depending on where it happens.

Wang and Dwivedi walk through the major spatial platforms, their tradeoffs in resolution and throughput, and how the field is moving from simple maps toward richer atlases of the brain. Recent method overviews make the same point: there is no single magic machine yet (Moses and Pachter, 2022) (Valihrach et al., 2024) (Gulati et al., 2024).

Why Neuroscientists Are Suddenly Acting Like Surveyors

This matters because brain disorders are painfully uneven. Alzheimer’s disease does not hit every cell equally. Depression does not rewrite the whole cortex in one neat font. Spatial tools let scientists see those local patterns instead of averaging them into mush.

That has already paid off. In Parkinson’s-related Lewy pathology, spatial transcriptomics has revealed molecular signatures in affected cortical neurons that would be easy to blur away in bulk tissue analyses (Goralski et al., 2024). In multiple sclerosis, recent work highlighted by Nature Neuroscience showed how spatial approaches can track lesion-specific cell states and disease evolution across tissue regions (Horan and Williams, 2024).

That is the real intrigue here. These methods do not just tell you what parts list the brain contains. They help show which parts are misfiring and which ones are standing too close to the biological equivalent of an electrical fire.

The Hype Is Real, But the Fine Print Is Also Real

Before anyone starts ordering a personalized brain map like it is a monogrammed bathrobe, there are hard problems. Resolution is still uneven across platforms. Data analysis is brutal. Tissue handling can make or break signal quality.

The NIH BRAIN Initiative has already helped produce enormous cell atlases, including a mouse brain atlas covering more than 32 million cells reported by NIH on June 26, 2024 (NIH, June 26, 2024). More recent reviews increasingly focus on reproducibility and the jump from clever maps to clinically useful biomarkers (Bonev et al., 2024) (Grases and Porta-Pardo, 2025).

In other words, the field is maturing. It is less "look, a shiny atlas" and more "can this actually help us diagnose or treat disease without the analysis pipeline bursting into flames?"

Why This Review Lands at the Right Moment

Wang and Dwivedi are writing at a useful time. The machinery is finally precise enough to be genuinely revealing, but still weird enough to require adult supervision. Their review frames single-cell and spatial transcriptomics as complementary instruments in the same clockwork. One tells you what each cog is made of. The other tells you where the cog sits.

If those tools keep improving, the payoff could be enormous: sharper disease subtypes, earlier molecular warning signs, and treatments aimed at the right cells in the right neighborhoods instead of lobbing chemistry at the whole organ and hoping the splash damage is therapeutic.

The brain has always been a Rube Goldberg machine with excellent public relations. These methods do not simplify it. They do something better. They let us watch the gears where they actually live.

References

1. Wang Q, Dwivedi Y. The Applications of Single-Cell and Spatial Transcriptomics in Neuroscience and Brain Disorders. Neurosci Biobehav Rev. 2026;106721. DOI: https://doi.org/10.1016/j.neubiorev.2026.106721
2. Piwecka M, Rajewsky N, Rybak-Wolf A. Single-cell and spatial transcriptomics: deciphering brain complexity in health and disease. Nat Rev Neurol. 2023;19(6):346-362. DOI: https://doi.org/10.1038/s41582-023-00809-y. PMCID: https://pmc.ncbi.nlm.nih.gov/articles/PMC10191412/
3. Moses L, Pachter L. An introduction to spatial transcriptomics for biomedical research. Genome Med. 2022;14(1):68. DOI: https://doi.org/10.1186/s13073-022-01075-1. PMCID: https://pmc.ncbi.nlm.nih.gov/articles/PMC9238181/
4. Valihrach L, Zucha D, Abaffy P, Kubista M. A practical guide to spatial transcriptomics. Mol Aspects Med. 2024;97:101276. DOI: https://doi.org/10.1016/j.mam.2024.101276
5. Gulati GS, D'Silva JP, Liu Y, Wang L, Newman AM. Profiling cell identity and tissue architecture with single-cell and spatial transcriptomics. Nat Rev Mol Cell Biol. 2024;26:11-31. DOI: https://doi.org/10.1038/s41580-024-00768-2
6. Bonev B, Castelo-Branco G, Chen F, et al. Opportunities and challenges of single-cell and spatially resolved genomics methods for neuroscience discovery. Nat Neurosci. 2024;27:2292-2309. DOI: https://doi.org/10.1038/s41593-024-01806-0
7. Goralski TM, Meyerdirk L, Breton L, et al. Spatial transcriptomics reveals molecular dysfunction associated with cortical Lewy pathology. Nat Commun. 2024;15:2800. DOI: https://doi.org/10.1038/s41467-024-47027-8
8. Horan K, Williams AC. Mapping out multiple sclerosis with spatial transcriptomics. Nat Neurosci. 2024;27:2270-2272. DOI: https://doi.org/10.1038/s41593-024-01798-x
9. Grases D, Porta-Pardo E. A practical guide to spatial transcriptomics: lessons from over 1000 samples. Trends Biotechnol. Published online September 19, 2025. DOI: https://doi.org/10.1016/j.tibtech.2025.08.020

Disclaimer: The image accompanying this article is for illustrative purposes only and does not depict actual experimental results, data, or biological mechanisms.